title: pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs.
authors.affiliation: School of Pharmacy, University of Geneva, Switzerland.
authors.forename: J C
authors.initials: JC
authors.lastname: Leroux
authors.forename: R M
authors.initials: RM
authors.lastname: Cozens
authors.forename: J L
authors.initials: JL
authors.lastname: Roesel
authors.forename: B
authors.initials: B
authors.lastname: Galli
authors.forename: E
authors.initials: E
authors.lastname: Doelker
authors.forename: R
authors.initials: R
authors.lastname: Gurny
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002219:Carbamates / Q000008:administration & dosage* / Q000097:blood; D002626:Chemistry, Pharmaceutical; D004285:Dogs; D005069:Evaluation Studies as Topic; D005260:Female; D016333:HIV Protease / Q000187:drug effects; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000097:blood; D006863:Hydrogen-Ion Concentration; D007413:Intestinal Mucosa / Q000378:metabolism; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage* / Q000097:blood; D010316:Particle Size; D012680:Sensitivity and Specificity
chemical_list: D002219:Carbamates; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; C098598:CGP 57813; D016333:HIV Protease